Current assets decreased 24.0%
Current assets changed -24.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Current assets changed -24.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Current ratio changed -36.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Working capital / assets changed -2092 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Revenue changed +35.1% from the comparable as-filed period.
Free-cash-flow proxy changed +43.9% from the comparable as-filed period.
Net income changed +35.7% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Working capital changed -115.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a sign change.
Operating margin changed +1272 basis points from the comparable as-filed period.
Shares outstanding changed +4.1% from the comparable as-filed period. The change ranks at the 100th percentile of 7 prior comparable changes.
Gross profit changed +34.1% from the comparable as-filed period.
Operating cash flow changed +22.0% from the comparable as-filed period.
Operating income changed +22.7% from the comparable as-filed period.
SBC / revenue changed -792 basis points from the comparable as-filed period.
Current liabilities changed +20.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Trade receivables changed +11.1% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Cash & equivalents changed -9.2% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Capital expenditure changed -54.7% from the comparable as-filed period.
R&D / revenue changed -628 basis points from the comparable as-filed period.
Research & development changed +15.3% from the comparable as-filed period.
Capex / revenue changed -97 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Receivables / revenue changed -1003 basis points from the comparable as-filed period.
Gross margin changed -50 basis points from the comparable as-filed period.
Total assets changed +6.0% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Stock-based compensation changed +4.8% from the comparable as-filed period.
Operating cash-flow margin changed -64 basis points from the comparable as-filed period.
Free-cash-flow margin changed +33 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Revenue changed +33.5% from the comparable as-filed period.
Net income changed +31.3% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating margin changed +1947 basis points from the comparable as-filed period.
Operating income changed +27.1% from the comparable as-filed period.
Free-cash-flow proxy changed +26.9% from the comparable as-filed period. The change ranks at the 67th percentile of 6 prior comparable changes.
Capex / revenue changed -357 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Gross profit changed +33.6% from the comparable as-filed period.
Capital expenditure changed -76.8% from the comparable as-filed period. The change ranks at the 33th percentile of 6 prior comparable changes. This reverses 5 consecutive comparable moves in the opposite direction.
SBC / revenue changed -748 basis points from the comparable as-filed period.
Operating cash flow changed +6.5% from the comparable as-filed period. The change ranks at the 0th percentile of 6 prior comparable changes.
Cash & equivalents changed -7.1% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Research & development changed +13.2% from the comparable as-filed period.
Gross margin changed +8 basis points from the comparable as-filed period.
Stock-based compensation changed +6.1% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.